CLINICAL_TRIALS
trial_result
· 2024-02-28
Clinical Trial Update: A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia [Phase 2]
Summary
Phase 2 trial evaluating three dose levels of luvadaxistat in adults with negative symptoms of schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocrine Biosciences | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2024-02-28